G1 Therapeutics g1therapeutics.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer. The company is advancing a pipeline of potential best-in-class and first-in-class drug candidates in multiple oncology indications.

G1 Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer. The company is advancing a pipeline of potential best-in-class and first-in-class drug candidate...Show all

Company (IPO / Went public)

Phone: 919-213-9836

Fax:

79 T.W. Alexander Drive
4401 Research Commons, Suite 105
Durham, 27709
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
G1 Therapeutics $209.7M May 17, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related G1 Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
AJU IB InvestmentVenture CapitalSeoul, South KoreaSeries C - II, Series C
Cowen Private InvestmentsOtherUnited StatesSeries C
Boxer CapitalCorporate VentureWindermere, Florida, United StatesSeries B
Cormorant Asset ManagementAsset/Investment ManagementBoston, Massachusetts, United StatesSeries C
Alexandria Venture InvestmentsCorporate VenturePasadena, California, United StatesSeries C - II
See all 15 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cdk inhibitors Nov 10, 2016 May 01, 2018 Patent
Transient protection of normal cells during chemotherapy Oct 07, 2016 Apr 03, 2018 Patent
Lactam kinase inhibitors Nov 10, 2016 Jan 02, 2018 Patent
Protection of renal tissues from ischemia through inhibition of the proliferative kinases cdk4 and cdk6 Nov 17, 2011 Nov 07, 2017 Patent
Lactam kinase inhibitors Dec 29, 2015 Aug 29, 2017 Patent
See all 34 patents